CymaBay Therapeutics
CBAY
#3624
Rank
NZ$6.49 B
Marketcap
NZ$56.59
Share price
0.00%
Change (1 day)
233.24%
Change (1 year)

CymaBay Therapeutics (CBAY) Fails to deliver data

Key failure to deliver metrics for CymaBay Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for CymaBay Therapeutics (CBAY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for CymaBay Therapeutics (CBAY) - since 2014

Volume in USD (price x number of shares), data since 2014

CymaBay Therapeutics (CBAY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$17.53 M37.55%
2023NZ$12.75 M682.01%
2022NZ$1.63 M-43.37%
2021NZ$2.87 M-80.81%
2020NZ$15 M1707.76%
2019NZ$0.82 M-82.75%
2018NZ$4.81 M170.66%
2017NZ$1.77 M118.41%
2016NZ$0.81 M-79.51%
2015NZ$3.97 M-91.13%
2014NZ$44.75 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
NZ$27.68 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.23 MNZ$0.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$7.81 MNZ$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$3.45 MNZ$32.36 M๐Ÿ‡บ๐Ÿ‡ธ USA